Improved tumor vascular function following high-dose epidermal growth factor receptor tyrosine kinase inhibitor therapy
Open Access
- 29 October 2007
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 26 (6), 1618-1625
- https://doi.org/10.1002/jmri.21196
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Escape from HER-family tyrosine kinase inhibitor therapy by the kinase-inactive HER3Nature, 2007
- Reversal of temporal and spatial heterogeneities in tumor perfusion identifies the tumor vascular tone as a tunable variable to improve drug deliveryMolecular Cancer Therapeutics, 2006
- ErbB2 Increases Vascular Endothelial Growth Factor Protein Synthesis via Activation of Mammalian Target of Rapamycin/p70S6K Leading to Increased Angiogenesis and Spontaneous Metastasis of Human Breast Cancer CellsCancer Research, 2006
- Early Antiangiogenic Activity of SU11248 Evaluated In vivo by Dynamic Contrast-Enhanced Magnetic Resonance Imaging in an Experimental Model of Colon CarcinomaClinical Cancer Research, 2005
- Bevacizumab in Combination With Fluorouracil and Leucovorin: An Active Regimen for First-Line Metastatic Colorectal CancerJournal of Clinical Oncology, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- Identification and validation of novel ERBB2 (HER2, NEU) targets including genes involved in angiogenesisInternational Journal of Cancer, 2004
- Tumor microvascular changes in antiangiogenic treatment: Assessment by magnetic resonance contrast media of different molecular weightsJournal of Magnetic Resonance Imaging, 2004
- In Vivo Assessment of Antiangiogenic Activity of SU6668 in an Experimental Colon Carcinoma ModelClinical Cancer Research, 2004
- The EGFR family and its ligands in human cancerEuropean Journal Of Cancer, 2001